Gainers
-
Spark Therapeutics, Inc. (NASDAQ: ONCE) shares climbed 120.09 percent to close at $113.48 on Monday after
Roche Holdings AG (OTC: RHHBY) announced
plans to acquire the company for $114.50 per share in cash.
-
Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) gained 74.66 percent to close at $26.06 after the company announced that
Ipsen would acquire the company for $25 per share in cash and up to an additional $6 per share depending on FDA acceptance of a
new drug application for palovarotene.
-
Planet Green Holdings Corp. (NYSE: PLAG)
gained 4.197 percent to close at $4.2875.
-
Uniqure NV (NASDAQ: QURE) shares rose
34.3 percent to close at $55.87. Cantor Fitzgerald maintained uniQure with an Overweight and raised the price target from $68
to $81. Shares of gene therapy companies are trading higher after Roche announced it would acquire Spark Therapeutics for
$114.50 per share in cash.
-
Phoenix New Media Limited (NYSE: FENG)
climbed 31.94 percent to close at $4.75 after announcing a letter of intent to sell a 32 percent stake in Particle for $448
million in cash. The company also reported a strategic investment in Tadu.
-
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) shares rose 30.5 percent to close at $1.84 after the company reported a
partnership with AllianceRx Walgreens to expand patient access to Probuphine.
-
China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) gained 25.45 percent to close at $6.31.
-
CRISPR Therapeutics AG (NASDAQ: CRSP)
shares rose 25.2 percent to close at $39.65. CRISPR Therapeutics posted Q4 loss of $0.92 per share on sales of $115,000. CRISPR
Therapeutics and Vertex Pharmaceuticals disclosed that the first patient has been enrolled in a Phase 1/2 clinical study of
CTX001 in severe SCD in the U.S. and is expected to be infused with CTX001 in mid-2019.
-
X Financial (NYSE: XYF) gained 23.99
percent to close at $7.08.
-
Libbey Inc. (NYSE: LBY) shares rose 23.88
percent to close at $4.41.
-
AVROBIO, Inc. (NASDAQ: AVRO) surged
21.63 percent to close at $16.98 on Monday.
-
Veritone, Inc. (NASDAQ: VERI) shares
jumped 20.45 percent to close at $6.36.
-
Stamps.com Inc. (NASDAQ: STMP) climbed
18.61 percent to close at $99.22 on a buy-the-dip rebound following a 50%+ decline on Friday.
-
SPI Energy Co., Ltd. (NASDAQ: SPI)
gained 17.15 percent to close at $2.80.
-
Akcea Therapeutics, Inc. (NASDAQ: AKCA) surged 16.72 percent to close at $31.91 after the company announced
Novartis licensed AKCEA-APO(a)-LRx; Akcea is set to receive a $150 million licensing fee that will be split with Ionis equally.
-
Hexindai Inc. (NASDAQ: HX) shares gained
16.42 percent to close at $3.97.
-
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) rose 16.32 percent to close at $7.20 on Monday after the company
received a notice of allowance from the US Patent and Trademark Office for claims directed to its novel voclosporin dosing
protocol.
-
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) gained 16.22 percent to close at $4.3000.
-
REGENXBIO Inc. (NASDAQ: RGNX) gained
16.17 percent to close at $54.02.
-
Oasmia Pharmaceutical AB (publ) (NASDAQ: OASM) gained 15.28 percent to close at $2.8184.
-
Neurotrope, Inc. (NASDAQ: NTRP) shares
rose 14.89 percent to close at $5.17.
-
Uniti Group Inc. (NASDAQ: UNIT) shares
surged 14.84 percent to close at $10.60.
-
Ocular Therapeutix, Inc. (NASDAQ: OCUL) gained 14.66 percent to close at $4.7700.
-
bluebird bio, Inc. (NASDAQ: BLUE)
shares gained 14.16 percent to close at $149.91 in sympathy with Roche's acquisition of Spark Therapeutics earlier Monday.
-
Mmtec, Inc. (NASDAQ: MTC) shares gained
13.4 percent to close at $5.50.
-
PPDAI Group Inc. (NYSE: PPDF) rose 13.32
percent to close at $5.02.
-
Abeona Therapeutics Inc. (NASDAQ: ABEO) surged 13.29 percent to close at $7.33.
-
Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) gained 13.14 percent to close at $10.76.
-
Cerecor Inc. (NASDAQ: CERC) climbed
13.06 percent to close at $6.06.
-
Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) rose 12.98 percent to close at $2.35.
-
Fate Therapeutics, Inc. (NASDAQ: FATE)
gained 12.83 percent to close at $16.27 on Monday.
-
MeiraGTx Holdings plc (NASDAQ: MGTX)
shares jumped 12.54 percent to close at $14.36.
-
Zosano Pharma Corporation (NASDAQ: ZSAN) gained 12.11 percent to close at $5.09.
-
Magenta Therapeutics, Inc. (NASDAQ: MGTA) surged 12.03 percent to close at $10.52.
-
Nightstar Therapeutics plc (NASDAQ: NITE) rose 11.98 percent to close at $15.89.
-
StoneCo Ltd. (NASDAQ: STNE) shares
gained 11.77 percent to close at $29.35 on Monday.
-
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) climbed 11.63 percent to close at $16.61.
-
Homology Medicines, Inc. (NASDAQ: FIXX) gained 11.47 percent to close at $27.02.
-
Audentes Therapeutics, Inc. (NASDAQ: BOLD) shares rose 11.38 percent to close at $29.26 in sympathy to Roche's
acquisition of Spark Therapeutics and an upgrade from Neutral to Buy from Chardan Capital.
-
Anaplan, Inc. (NYSE: PLAN) gained 10.3
percent to close at $36.83 after reporting Q4 results.
-
Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 9.77 percent to close at $17.52.
-
Solid Biosciences Inc. (NASDAQ: SLDB)
rose 9.6 percent to close at $9.82.
-
Danaher Corporation (NYSE: DHR) gained
8.52 percent to close at $123.15 after the company announced it would buy General Electric's Life Sciences business for $21.4
billion and that the acquisition would be accretive to adjusted earnings.
-
Summit Wireless Technologies, Inc. (NASDAQ: WISA) shares rose 8.23 percent to close at $2.50.
-
Carter's, Inc. (NYSE: CRI) rose 8.12
percent to close at $100.03 following upbeat Q4 results.
-
Wayfair Inc (NYSE: W) gained 6.89 percent
to close at $160.28 after multiple banks reiterated the company's stock with positive ratings following a strong Q4 earnings
beat.
-
Westinghouse Air Brake Technologies Corp (NYSE: WAB) gained 6.41 percent to close at $78.06 following Q4 results.
-
General Electric Company (NYSE: GE) shares
gained 6.39 percent to close at $10.82 after the company agreed to sell its BioPharma business to Danaher
Corporation (NYSE: DHR) for $21.4 billion.
-
Amicus Therapeutics, Inc. (NASDAQ: FOLD) gained 5.87 percent to close at $12.44 after the FDA granted
breakthrough therapy designation to the company's AT-GAA.
-
Jianpu Technology Inc. (NYSE: JT) rose
5.83 percent to close at $6.54 after reporting upbeat Q4 results.
-
Voyager Therapeutics, Inc. (NASDAQ: VYGR) rose 5.64 percent to close at $13.86 on Monday after surging 22.85
percent on Friday.
-
Editas Medicine, Inc. (NASDAQ: EDIT)
rose 5.33 percent to close at $20.93.
Losers
-
Windstream Holdings, Inc. (NASDAQ: WIN)
shares dipped 46.89 percent to close at $0.4530 on rumors of the company declaring bankruptcy.
-
Achieve Life Sciences, Inc. (NASDAQ: ACHV) shares tumbled 19.7 percent to close at $2.65 on Monday after rising
82.32 percent on Friday.
-
Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) shares declined 17.21 percent to close at $0.2401 following late-Friday
Dow Jones report that the companywon court permission to draw down remainder of a $155 million bankruptcy financing package.
-
Sunlands Online Education Group (NYSE: STG) shares fell 17.18 percent to close at $4.05.
-
Travelzoo (NASDAQ: TZOO) dipped 14.12
percent to close at $12.71.
-
Harpoon Therapeutics, Inc. (NASDAQ: HARP) shares fell 14.06 percent to close at $14.36.
-
Tyme Technologies, Inc. (NASDAQ: TYME)
dropped 12.37 percent to close at $2.62.
-
eHealth, Inc. (NASDAQ: EHTH) dropped
11.36 percent to close at $56.25.
-
Ramaco Resources, Inc. (NASDAQ: METC)
fell 10.64 percent to close at $5.29 after reporting preliminary 2018 results.
-
Dorman Products Inc. (NASDAQ: DORM)
declined 10.42 percent to close at $81.27 after the company issued weak FY19 earnings forecast.
-
Textainer Group Holdings Limited (NYSE: TGH) dipped 10.38 percent to close at $11.40.
-
Research Frontiers Incorporated (NASDAQ: REFR) tumbled 9.83 percent to close at $2.11 on Monday.
-
Overstock.com, Inc. (NASDAQ: OSTK)
dropped 9.2 percent to close at $18.06.
-
Riot Blockchain, Inc. (NASDAQ: RIOT)
shares declined 9.11 percent to close at $3.59.
-
Melinta Therapeutics, Inc. (NASDAQ: MLNT) shares dropped 9.02 percent to close at $5.95.
-
Blink Charging Co. (NASDAQ: BLNK)
shares tumbled 8.83 percent to close at $3.20.
-
Kandi Technologies Group, Inc. (NASDAQ: KNDI) dropped 8.54 percent to close at $8.25.
-
Cronos Group Inc (NASDAQ: CRON) fell
7.62 percent to close at $20.25. Analysts at Jefferies initiated coverage on Cronos with an Underperform rating.
-
B.O.S Better Online Solutions Ltd. (NASDAQ: BOSC) shares fell 5.4 percent to close at $3.33. BOS Better Online Solutions
posted Q4 earnings of $0.11 per share on sales of $9.1 million.
-
OncoCyte Corporation (NYSE: OCX) fell
5.19 percent to close at $3.47 after declining 8.50 percent on Friday.
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.